Company Information
CIN
Status
Date of Incorporation
06 August 2003
State / ROC
Delhi / ROC Delhi
Last Balance Sheet
31 March 2022
Last Annual Meeting
30 September 2022
Paid Up Capital
8,326,010
Authorised Capital
9,000,000
Directors
Raman Aggarwal
Director/Designated Partner
over 2 years ago
over 2 years ago
Arunkumar Chamanlal Mittal
Director/Designated Partner
over 21 years ago
over 21 years ago
Bharat Bhushan Aggarwal
Director/Designated Partner
over 22 years ago
over 22 years ago
Rajeev Aggarwal
Director/Designated Partner
over 22 years ago
over 22 years ago
Registered Trademarks
[Class : 5] Pharamceutical And Medicinal Preparations Included In Class 5.
Trade mark is likely to be removed due to non filing of Renewal request within prescribed time limit In case of any discripancy contact respective TM Registry.
[Class : 5] Pharamceutical And Medicinal Preparations Included In Class 5.
Trade mark is likely to be removed due to non filing of Renewal request within prescribed time limit In case of any discripancy contact respective TM Registry.
[Class : 5] Pharmaceutical And Medicinal Preparations, Inlcluded In Class 5.
Trade mark is likely to be removed due to non filing of Renewal request within prescribed time limit In case of any discripancy contact respective TM Registry.
View +3 more Brands for Divus Laboratories Limited.
Charges
19 February 2004
Indian Overseas Bank
41 Crore
19 February 2004
Indian Overseas Bank
0
19 February 2004
Indian Overseas Bank
0
19 February 2004
Indian Overseas Bank
0
Documents
Form AOC-4-29022020_signed
Form MGT-7-29022020_signed
Statement of the fact and reasons for not adopting financial Statements in the annual general meeting (AGM)-28022020
Optional Attachment-(2)-28022020
Optional Attachment-(1)-28022020
List of share holders, debenture holders;-28022020
Directors report as per section 134(3)-28022020
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-28022020
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-15112018
List of share holders, debenture holders;-15112018
Optional Attachment-(1)-15112018
Optional Attachment-(2)-15112018
Statement of the fact and reasons for not adopting financial Statements in the annual general meeting (AGM)-15112018
Directors report as per section 134(3)-15112018
Form AOC-4-15112018_signed
Form MGT-7-15112018_signed
Form AOC-4-17022018_signed
Statement of the fact and reasons for not adopting financial Statements in the annual general meeting (AGM)-15022018
Optional Attachment-(3)-15022018
Optional Attachment-(2)-15022018
Optional Attachment-(1)-15022018
Directors report as per section 134(3)-15022018
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-15022018
Form AOC-4-08012018_signed
Form MGT-7-08012018_signed
Optional Attachment-(2)-07012018
Optional Attachment-(3)-07012018
Optional Attachment-(1)-07012018
Directors report as per section 134(3)-07012018
Copy of Financial Staements duly authenticated as per section 134 (Including Boards report, auditors report and other documents)-07012018
